Intervention
Mannitol
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 18 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
18 shownCopeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia SyndromeNCT07569861 · 2026-06-16
RECRUITINGOpen-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.NCT06473779 · 2024-09-30
ACTIVE_NOT_RECRUITINGA Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic CoughNCT05660850 · 2023-03-22
COMPLETEDCoagulation Activation by Hyperosmolar Agents in Intracranial HypertensionNCT03409237 · 2020-12-03
WITHDRAWNEffect of Intravenous Administration of Mannitol on ONSD in Patients With Raised ICPNCT04188353 · 2019-02-24
COMPLETEDMannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic AsthmaNCT03620422 · 2019-01-11
COMPLETEDThe Effect of Deep Inhalation on Mannitol ResponsivenessNCT03505489 · 2018-06-01
COMPLETEDEffect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robotic ProstatectomyNCT03214055 · 2017-07-12
COMPLETEDTopical Menthol +/- Mannitol for Painful Diabetic Peripheral NeuropathyNCT02728687 · 2017-03-15
COMPLETEDAsthma Exacerbations and Vascular FunctionNCT02630511 · 2015-12-01
COMPLETEDThe Leaky Lung TestNCT02306473 · 2015-10-01
COMPLETEDChange in Airway Responsiveness After Allergen ExposureNCT01699594 · 2012-10-01
COMPLETEDDouble Blind Study of Hypertonic Saline vs Mannitol in the Management of Increased Intracranial Pressure (ICP).NCT01108744 · 2012-01-01
WITHDRAWNOsmotic Therapy for Treatment of Intracranial Hypertension for Traumatic Brain InjuryNCT01215019 · 2010-10-01
WITHDRAWNHypertonic Saline vs. Mannitol for Elevated Intercranial PressureNCT01111682 · 2010-04-01
TERMINATEDMannitol vs HS to Treat ICHT After Severe TBI : Comparison on PtiO2 and Microdialysis ValuesNCT01028339 · 2008-07-01
TERMINATEDEffects of Copaxone in the Retinal Function in Diabetic Patients After PanphotocoagulationNCT00677664 · 2006-07-01
UNKNOWNCerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured PatientsNCT00125229 · 2005-08-01
TERMINATEDCommon conditions
Asthma4Traumatic Brain Injury4Elevated Intracranial Pressure2Intracranial Hypertension2Allergic Asthma1Allergy1Arginine Vasopressin Deficiency1Cerebral Edema1Chronic Refractory Cough (CRC) With Non-atopic Asthma1Cough1CRC With Atopic Asthma1CRC With Chronic Obstructive Pulmonary Disease1CRC With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis1Diabetic Peripheral Neuropathy1Diabetic Retinopathy1Lung Diseases, Obstructive1Primary Polydipsia1Prostate Cancer1Raised Intracranial Pressure1Reactive Airway Disease1Severe Asthma1Unexplained Chronic Cough1
Leading sponsors
University of Saskatchewan
2
Asan Medical Center
1
AstraZeneca
1
Beth Israel Deaconess Medical Center
1
Direction Centrale du Service de Santé des Armées
1
Federal University of São Paulo
1
Genentech, Inc.
1
Indiana University
1
McMaster University
1
Neuromed IRCCS
1
The University of Texas Health Science Center at San Antonio
1
Tribhuvan University Teaching Hospital, Institute Of Medicine.
1
University Hospital, Basel, Switzerland
1
University of Alberta
1
University of British Columbia
1
Trial status mix
COMPLETED9
TERMINATED3
WITHDRAWN3
ACTIVE_NOT_RECRUITING1
RECRUITING1
UNKNOWN1
Phase mix
NA6
PHASE34
PHASE22
EARLY_PHASE11
PHASE11
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.